PCRX vs PTCT

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 12, 2026

PCRX

48.2
AI Score
VS
PCRX Wins

PTCT

42.4
AI Score

Investment Advisor Scores

PCRX

48score
Recommendation
HOLD

PTCT

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric PCRX PTCT Winner
Forward P/E 6.566 24.6305 PCRX
PEG Ratio 11.2121 0.81 PTCT
Revenue Growth 6.2% 101.5% PTCT
Earnings Growth -30.0% 0.0% PTCT
Tradestie Score 48.2/100 42.4/100 PCRX
Profit Margin 2.0% -3.8% PCRX
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

PCRX 1M: +7.0% · 3M: +8.6% PTCT 1M: -9.1% · 3M: -11.6%

Current Technical Phase

PCRX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 49

RSI (14): 49.0 · Price: $25.36

PTCT

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.5%), weak momentum, RSI 33

RSI (14): 33.4 · Price: $66.06

Fundamentals Snapshot

Metric PCRX PTCT
Market Cap
Forward P/E 7.4 26.4
Trailing P/E 74.0
Revenue (TTM)
Revenue Growth 0.1% 1.0%
Gross Margin 0.8% 0.5%
Operating Margin 0.1% 0.4%
EPS 0.34 -0.67
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PCRX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.